# A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma

> **NCT04455139** · PHASE2 · TERMINATED · sponsor: **Prof. Beck Popovic Maja** · enrollment: 2 (actual)

## Conditions studied

- Eye Cancer, Retinoblastoma

## Interventions

- **DRUG:** Topotecan
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT04455139
- **Lead sponsor:** Prof. Beck Popovic Maja
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-15
- **Primary completion:** 2023-05-22
- **Final completion:** 2023-05-22
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulties in recruiting patients due to changing in treatment standards for the target population
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455139, "A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04455139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*